Despite a preliminary theory that health insurers could potentially hold too much buyer power, resulting in a loss of quality of consulting and preventative care for consumers, the Competition Commission has expressed support of health insurers in its most recent update of a widespread probe into the UK’s private healthcare sector. A common complaint, according to reports, often involves Bupa, one of the UK’s largest private medical insurers; the CC has received complaints that the insurer’s fee schedule reduces consultation quality and hinders innovation. The Commission has said it has “not seen evidence” of these claims, however. While its update did not come down hard on insurers, the Commission did suggest that there may be cause for concern within the private hospital operators’ sector.
Featured News
DOJ Considers Reviving Collaboration Guidelines to Clarify Antitrust Rules
Mar 25, 2026 by
CPI
JetBlue Weighs Sale to Rival Airlines Amid Strategic Review
Mar 25, 2026 by
CPI
Chile Approves Joint Codelco–Anglo American Copper Project
Mar 25, 2026 by
CPI
Bernie Sanders Unveils Bill to Ban Data Centers Until Congress Passes AI Regulation
Mar 25, 2026 by
CPI
CFTC Unveils New Task Force to Focus on AI, Crypto, Prediction Markets
Mar 25, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers